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THE NATIONAL BIOETHICS ADVISORY COMMISSION:
BRIDGING THE GAPS IN HUMAN SUBJECTS
RESEARCH PROTECTION
JAMES F. CHILDRESS, PH.D.*
I. INTRODUCTION: THE FORMATION OF THE NATIONAL BIOETHICs
ADVISORY COMMISSION
The National Bioethics Advisory Commission (NBAC) was estab-
lished by a Presidential Executive Order in late 19951 to "provide ad-
vice and make recommendations to the National Science and
Technology Council (NSTC) [in the White House], other appropriate
entities and the public, on bioethical issues arising from research on
human biology and behavior, including the clinical applications of
that research."'
According to NBAC's charter, its eighteen presidentially-ap-
pointed members are to be selected from "knowledgeable non-gov-
ernment experts and community representatives with special
qualifications and competence to deal effectively with bioethical is-
sues."3 At least one member should come from each of five catego-
ries: (1) philosophy/theology, (2) social/behavioral science, (3) law,
(4) medicine/allied health professions, and (5) biological research.4
NBAC's members were appointed during 1996 and its first meeting
was held in October 1996. Why NBAC, why now? In the 1970s, the
disclosure of several unethical experiments, including the U.S. Public
Health Service's "Tuskegee Study of Syphilis in the Negro Male,"5 led
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1. Exec. Order No. 12,975, 60 Fed. Reg. 52,063 (1995) [hereinafter Exec. Order No.
12975].
2. National Bioethics Advisory Commission Charter (July 26, 1996) (on file with the
Journal of Health Care Law & Policy).
3. Id.
4. See id.
5. The Tuskegee Syphilis Study Legacy Comm., Final Report of the Tuskegee Syphilis
Study Legacy Committee (citingJean Heller, Syphilis Victims in the U.S. Study Went Untreated
for 40 Years, N.Y. Times, July 26, 1972, at 1, 8) (May 20, 1996) (unpublished report, on file
with the Journal of Health Care Law & Policy). The Tuskegee Syphilis Study was initiated by
the U.S. Public Health Service to investigate the natural history of syphilis in 399 poor
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to the formation of the National Commission for the Protection of
Human Subjects of Biomedical and Behavioral Research ("National
Commission"), which made several substantive and procedural recom-
mendations for protecting research subjects.6 Procedurally, the Na-
tional Commission relied on institutional review boards (IRBs), which
had already emerged as important mechanisms to protect human sub-
jects.7 Substantively, it formulated several principles and guidelines,'
many of which became formal regulations in the Department of
Health, Education and Welfare (later the Department of Health and
Human Services) 9 and were later incorporated into what became
known as the "Common Rule," which will be discussed below.'" Every-
thing seemed settled: In the 1980s, discussants of research ethics ob-
served that the main controversies concerned the use of animals
rather than the use of humans in research. However, in a prophetic
note, Alexander M. Capron observed in 1989 that "today the subject
[of research involving human subjects] is often naively viewed as one
of settled ethical principles, detailed statutory and regulatory require-
ments, and multifaceted procedures. History suggests that such
claims must be viewed skeptically: the principles may be less conclu-
sive and the guidelines less protective than they appear."'"
The work of the Advisory Committee on Human Radiation Ex-
periments (ACHRE), chaired by Ruth Faden of the Johns Hopkins
University School of Public Health from 1994 to 1995, paved the way
for a new commission, with the study of protections in research involv-
ing human subjects as one of its two main tasks. 2 ACHRE was estab-
lished by President Clinton partly in response to stories that put a
Black sharecroppers from Alabama. See id. at 2. Physicians conducting the study deceived
the participants by telling them they were being treated for "bad blood." Id. The physi-
cians deliberately denied treatment to participants and went to great lengths to ensure that
they would not receive therapy from other sources. See id The participants received free
meals, free medical exams, and burial insurance in exchange for their participation. See id.
6. See Belmont Report: Ethical Principles and Guidelines for Research Involving
Human Subjects, 79 Fed. Reg. 12,065 (1979) [hereinafter Belmont Report]. The Belmont
Report was the product of the National Commission's monthly deliberations over a period
of four years. See THE NATIONAL COMMISSION FOR THE PROTECTION OF HUMAN SUBJECTS OF
BIOMEDICAL AND BEHAVIORAL RESEARCH, THE BELMONT REPORT: ETHICAL PRINCIPLES AND
GUIDELINES FOR THE PROTECTION OF HUMAN SUBJECTS OF RESEARCH 2 (GPO Pub. No. 201-
778/80319) (1988).
7. See id
8. See, e.g., id.
9. See Regulations for Protection of Human Subjects, 45 C.F.R. § 46 (1996).
10. See infra notes 32-35 and accompanying text.
11. Alexander M. Capron, Human Experimentation, in MEDICAL ETHICS 125, 128 (ROBERT
M. VEATCH ED., 1989).
12. ArvisORY COMM. ON HUMAN RADIATION EXPERIMENTS, FINAL REPORT (GPO Pub. No.
061-000-00-848-9) (1995).
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human face on some information and data that had been around for
years. For instance, a series of reports in the Albuquerque Tribune dis-
closed the names of Americans who had been injected with pluto-
nium, the man-made material that was a key ingredient of the atom
bomb." ACHRE examined the records of several thousand experi-
ments funded and conducted, mostly in secret, by different branches
of the federal government as part of the Cold War.14 These experi-
ments included feeding cereal with minute amounts of radioactive
material to the science club at the Fernald School for the Retarded,'
5
total body irradiation of cancer patients, 6 and testicular irradiation of
inmates in Oregon and Washington prisons." ACHRE not only made
recommendations about how the federal government should now re-
spond to its past actions, but also how it could learn from the legacy of
these Cold War experiments.1 8 NBAC was one result: it was designed
to respond to some specific issues raised by ACHRE, but also, more
generally, to provide a national public forum for dialogue on ethical
issues in research involving human subjects. 9
II. NBAC's PIUOITIES
According to its charge, NBAC must give first priority to two main
areas: (1) protection of the rights and welfare of human research sub-
jects; and (2) issues in the management and use of genetic informa-
tion including, but not limited to, human gene patenting.2 ° In
addition to responding to NSTC's requests for advice and recommen-
dations, NBAC may accept congressional and public. suggestions, and
identify other bioethical issues that it wants to examine, subject to
NSTC's approval.21
Beyond the tasks that have first priority, NBAC, according to its
charter, shall use four criteria in determining its priorities: (1) the
public health or public policy urgency of the bioethical issue; (2) the
relation of the bioethical issue to the goals for federal investment in
-science and technology; (3) the absence of another body able to delib-
13. See id. at 2.
14. See id.
15. See id. at 342.
16. See i&. at 366.
17. See id. at 421.
18. See id. at xxiv.
19. See U.S. Gov'T HUMAN RADIATION INTERAGENCY WORKING GROUP, BUILDING PUBLIC
TRUST: ACTIONS TO RESPOND TO THE REPORT OF THE ADVISORY COMMITTEE ON HUMAN RADI-
ATION EXPERIMENTS 11 (GPO PUB. No. 061-000-00880-2) (1997).
20. See National Bioethics Advisory Commission Charter (July 26, 1996).
21. See id.
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erate fruitfully about the bioethical issue; and (4) the extent of gov-
ernment-wide interest in the issue. 22 The charter further notes that
NBAC will usually consider only bioethical issues that are of interest to
more than one department.23
NBAC was divided into two formal subcommittees in order to ad-
dress its two tasks with top priority.24 One is the Human Subjects Sub-
committee (HSSC), which I chair. The other is the Genetics
Subcommittee, which is chaired by Tom Murray of Case Western Re-
serve University. Although these subcommittees are responsible for
most of the preliminary work in their respective areas, NBAC as a
whole is ultimately responsible for producing any reports or making
any recommendations.2 5
These two subcommittees' responsibilities differ considerably.
The Genetics Subcommittee has to work largely from scratch because
of the general absence - or, at most, the patchwork - of laws, regu-
lations, and guidelines. It has decided to concentrate first on stored
tissue samples. Although this topic might seem, at first glance, quite
narrow, it is, in fact, broadly significant because of the crucial ques-
tions it raises about the ownership of such samples; the kind of con-
sent, if any, that must be provided for the use of tissue samples in
research; the way DNA research involves parties other than the one
from whom the tissue came; concerns about discrimination; and the
like. Obviously this topic also connects in important ways with human
subjects research, as reflected, for instance, by an interagency confer-
ence in late June, 1997, which focused on "Genetics Research and
Human Subjects: The Changing Landscape."2 6
By contrast, extensive and substantial governmental regulations
and guidelines already exist for research involving human subjects,
along with settled professional standards.27 Hence, the HSSC's task is
to examine what appears in law, regulations, guidelines, and practices
22. See id. These criteria also appear, with slightly different wording, in the Executive
Order that established the Commission. See Exec. Order No. 12975, supra note 1.
23. See National Bioethics Advisory Commission Charter Uuly 26, 1996).
24. These two subcommittees were created by NBAC's chair, Princeton's president,
Harold Shapiro.
25. See National Bioethics Advisory Commission Charter Uuly 26, 1996).
26. Dep't of Energy/Protection of Human Subjects Program, Nat'l Inst. of Health (NIH) Human
Genome Program, and the Interagency Human Subjects Subcommittee/Office of Protection from Re-
search Risks, Interagency Human Subjects Conference Genetics Research and Human Subjects: The
Changing Landscape (June 26-27, 1997); see also Eric T. Juengst, Respecting Human Subjects in
Genome Research: A Preliminary Policy Agenda, in THE ETmics OF RESEARCH INVOLVING HUMAN
SUBJECTS: FACING THE 21s'r CENTURY, 401-429 (Harold Y. Vanderpool, ed., 1996) (discuss-
ing the connections between human subjects research and genetics research).
27. See Regulations for Protection of Human Subjects, 45 C.F.R. § 46 (1996).
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to determine where there are important "gaps." Whereas the Genet-
ics Subcommittee often has to create anew rather than improve what
already exists, the main task for the HSSC is to identify and plug gaps,
often by modifying or adding to what already exists. This does not
mean, of course, that the HSSC's task is simple, because there will be
vigorous debates about perceived gaps and about possible ways to
close them while taking into account major moral principles and val-
ues. Keeping with the metaphor of gaps, I now want to examine sev-
eral possible areas of concern.
III. POSSIBLE GAPS IN HUMAN SUBJECTS PROTECTIONS
A. Federal Agency Protection of Human Subjects
NBAC has one mandated task in the area of research involving
human subjects. That task, as established by the Presidential Execu-
tive Order, required each executive branch department and agency
conducting, supporting, or regulating research involving human sub-
jects to review its policies and procedures for protecting those sub-
jects' rights and welfare, in light of the recommendations contained
in the ACHRE report.2" These departments and agencies were also
instructed to report the results of their reviews to NBAC within 120
days. 2 9 These reports were expected to identify "measures that the
department or agency plans or proposes to implement to enhance
human subject protections."30
The departments and agencies submitted their reports, even
though NBAC did not exist until several months later. Within its first
year, despite the delays created by "Dolly,"3 ' NBAC expects to issue a
report on federal department and agency protection of human sub-
jects. In preparing this report, NBAC is seeking to determine whether
there are gaps in adherence to the Federal Policy for the Protection of
Human Subjects (known as the Common Rule) .12
In 1991, sixteen federal departments or agencies accepted the
Common Rule,33 according to which federally. conducted or spon-
28. See Exec. Order No. 12975, supra note 1.
29. See id.
30. See id.
31. Virtually all NBAC's work between late February and early June focused on a report
and recommendations on the cloning of humans - a task that President Clinton asked
NBAC to complete within 90 days, in the wake of the report of Scottish researchers' success
in cloning a sheep. See infra note 40.
32. See 45 C.F.R. § 46.
33. Federal Policy for the Protection of Human Subjects; Notices and Rules, 56 Fed.
Reg. 28,002-32 (1991) (codified at 34 C.F.R- pt. 97). The Food and Drug Administration
1998]
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sored research cannot proceed without local IRB approval of the re-
search protocol, according to several criteria which include: Risks to
subjects must be minimized and must be "reasonable in relation to
anticipated benefits, if any, to subjects and the importance of the
knowledge that may reasonably be expected to result;"-and selection
of subjects must be equitable (fair, just) in light of research purposes
and setting and the special problems of vulnerable populations, in-
cluding children, pregnant women, mentally disabled persons, or eco-
nomically or educationally disadvantaged persons (special guidelines
apply to some of these populations). The criteria also require in-
formed consent; monitoring, if appropriate; and privacy and
confidentiality.3 4
Although written reports from federal departments and agencies
were available by the time NBAC came into existence, NBAC wanted
to know more about the structures and processes of protecting human
subjects than most written reports provided. Thus, it proceeded to
gather additional information through interviews conducted by a
team of NBAC staff. The interviews and reports address both struc-
tures, which have formally been put in place, and processes of implementa-
tion. Efforts to learn more about the structures in Phase I, conducted
by NBAC, involve interviews with the responsible agency personnel.
Efforts to learn more about the processes in Phase II concentrate on
individuals in each organization who have direct responsibility for, or
participate in, its IRBs or review of extramural research in a few
agencies.3
5
It is too early to anticipate what recommendations, if any, NBAC
may advise to strengthen federal department and agency protection of
human research subjects. Although NBAC will pay particular atten-
tion to federal adherence to the Common Rule, it is also interested in
other measures that some departments and agencies may have already
devised and adopted to protect human subjects because such innova-
tions may be instructive to other agencies.
has also adopted the Common Rule for research involving products it regulates. See id at
28,004.
34. See id. at 28,015-16.
35. See Human Subjects Subcommittee, National Bioethics Advisory Committee, Survey
of Federal Departments and Agencies Concerning Their Implementation of Protection
For Human Subjects in Research (unpublished research protocol, on file with author).
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B. Extension of the Common Rule to Other Federal Agencies and to
Privately-Funded Research
In its consideration of possible gaps in the protection of human
research subjects, NBAC will consider whether the Common Rule
should be extended to federal agencies that have not already en-
dorsed it. NBAC will also consider whether the Common Rule should
be extended to research not currently addressed in some federal
agencies, because it is not now viewed as research, that is, as a system-
atic effort to generate generalizable knowledge.
At NBAC's first meeting, Gary Ellis, Director of the Office of Pro-
tection from Research Risks, noted that the most vulnerable research
subjects are those not protected by the Common Rule - for example,
subjects in privately-funded research in settings without multiple as-
surances. 6 In addition, Commissioner Alta Charo has argued
strongly over several months that NBAC ought to affirm the principle
or ideal or universal protection through IRB review and informed
consent."v NBAC could endorse this principle or ideal without regard
to how it might be implemented - for example, without recom-
mending Senate Bill 193, "Human Research Subjects Protections Act
of 1997," introduced by SenatorJohn Glenn, or any other specific leg-
islation.3 8 As a principle or ideal, it could serve as a standard or point
of reference for all our discussions and deliberations. However, some
commissioners thought that it would be preferable to consider the
need for such protection, how it might be implemented, and how
much the implementation might cost before affirming the principle
or ideal.3 9 Commissioner Charo's proposal was finally adopted in the
context of an NBAC recommendation regarding the cloning of
humans:
If a legislative ban is not enacted, or if a legislative ban is ever
lifted, clinical use of somatic cell nuclear transfer techniques
to create a child should be preceded by research trials that
are governed by the twin protections of independent review
36. See Gary B. Ellis, Remarks before the National Bioethics Advisory Commission (Oc-
tober 4, 1996), in BIOLAW, December 1996, at S:242-43. See also, infra note 60 (defining
multiple assurances).
37. See, e.g., Comm'r Alta Charo, Proposal at Meeting of the National Bioethics Advi-
sory Commission, 35 (March 13, 1997) (unpublished transcript, on file with author).
38. S. 193, 105th Cong. (1997).
39. See generally, Meeting of the National Bioethics Advisory Commission, Human Sub-
jects Sucommittee (March 13, 1997) (unpublished transcript, on file with the author).
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and informed consent, consistent with existing norms of
human subjects protection.4 °
C. Gaps and Other Problems in the Common Rule Itself
Many worry that extending the Common Rule to plug gaps in
protection will be inadequate unless some gaps are closed in the Com-
mon Rule itself. One area of widespread public interest is the protec-
tion of vulnerable or special populations. Guidelines already exist for
some vulnerable populations such as prisoners,41 children,42 and
pregnant women. 43 NBAC tentatively plans, sometime next year, to
examine some of these guidelines in more detail by carefully looking
at the guidelines for research with children and adolescents, with par-
ticular attention to ways of defining and determining such categories
as minimal risk, greater than minimal risk, and minor increase over
minimal risk.44 One author has characterized vulnerability in two
ways: (1) vulnerability due to coercion and manipulation (e.g., prison-
ers); and (2) vulnerability because of limited or no capacity to consent
(e.g., children)." However, the HSSC is interested in conceptualizing
"vulnerability" more broadly by exploring ideas such as relational vul-
nerability, that is, vulnerability in the context of interactions between
researcher and subject, rather than simply as a characteristic of the
research subject.46
At the first HSSC meeting, cognitively impaired or decisionally
impaired research subjects (the exact description of this population is
not yet settled) emerged as a possibly vulnerable population in need
of additional protections.47 As a result, subsequent HSSC meetings
have regularly focused on this population.4" The National Commis-
sion had proposed guidelines for those institutionalized as mentally
40. REPORT AND RECOMMENDATIONS OF THE NATIONAL BIOETHICS ADVISORY COMMISSION,
CLOtNc HUMAN BEINGS at iv (1997).
41. See 45 C.F.R. §§ 46.301-306 (1996).
42. See id. §§ 46.401-409.
43. See id. §§ 46.201-211.
44. See Meeting of the National Bioethics Advisory Commission, Human Subjects Sub-
committee (December 16, 1996) (unpublished transcript, on file with the Journal of Health
Care Law & Policy) [hereinafter Meeting of the NBAC].
45. See Loretta M. Kopelman, Research Policy: Risk and Vulnerable Groups, 4 ENCYCLOPEDIA
OF BIOETHICS 2291-92 (WARREN THOMAS REICH ED., REV. ED. 1995).
46. See Meeting of the NBAC, supra note 44.
47. See id.
48. See id; see also Meeting of the National Bioethics Advisory Commission, Human Sub-
jects Subcommittee Uuly 15, 1997) (unpublished transcript, on file with Journal of Health
Care Law & Policy) [hereinafter July 15, 1997 Meeting of the NBAC].
NATIONAL BIOETHICS ADVISORY COMMISSION
infirm.49 However, these guidelines were never adopted for various
reasons, including additional and (too many) burdensome mecha-
nisms such as the use of consent auditors in all cases and possibly a
subjects advocate, that the Department of Health, Education, and
Welfare (DHEW) had added in proposing regulations. 0 The trend
toward de-institutionalization of the mentally ill accelerated, thereby
making the proposed guidelines less relevant. According to many, the
lack of guidelines protecting human subjects poses a serious problem:
some necessary research is not conducted while other research is
poorly conducted." The HSSC will probably draft a report and make
recommendations on research with decisionally impaired subjects for
NBAC's consideration by early 1998. The process will include review
of testimony and papers from various researchers and from the Na-
tional Institute of Mental Health, as well as public testimony, includ-
ing public hearings conducted in September, 1997.
D. Possible Gaps in Implementation: Questions About IRBs
The Common Rule is currently implemented through local IRBs.
IRBs must examine each research protocol (except for those in ex-
empt categories) to determine whether the protocol meets the criteria
to justify the use of human subjects.5" Over the last twenty years, re-
search involving human subjects has greatly expanded, and the
number of protocols has increased dramatically.5" In addition, many
protocols are now multi-site protocols involving various teams of inves-
tigators and large numbers of research subjects.54 Although regula-
tions have increased, institutional support given to IRBs is often
minimal, and individual members feel overworked and underap-
preciated.55 Furthermore, conflicts of interest are not uncommon.56
49. See National Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research, RESEARCH INVOLVING THOSE INSTITUTIONALIZED As MENTALLY INFIRM,
DHEW Publication No. (OS) 78-0006 (February 2, 1978).
50. See Proposed Regulation on Research Involving Those Institutionalized as Mentally
Disabled, 43 Fed. Reg. 223, 53950-56.
51. See, e.g., Richard J. Bonnie, Research With Cognitively Impaired Subjects, 54 ARCHIVES
GEN. PSYCHIATRY (1997); Rebecca Dresser, Mentally Disabled Research Subjects, 276JAMA 67
(1996).
52. See supra note 35 and accompanying text.
53. Donald F. Phillips, Institutional Review Boards Under Stress: Will They Explode or
Change?, 276JAMA 1623 (1996).
54. See id. at 1623-24.
55. See id. at 1625.
56. See id.
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As a result, worries abound that IRBs may not be able to adequately
protect research subjects.5 7
The truth is that we don't really know how well IRBs are protect-
ing research subjects, and it is difficult, as well as very expensive, to try
to find out. Even if there is considerable variability in IRBs' judg-
ments about particular protocols and in what they require, for in-
stance, in the way of disclosure of information for informed consent/
refusal, it may still be unclear whether this variability falls within an
acceptable or an unacceptable range.
In Building Public Trust, the United States Government Human
Radiation Interagency Working Group notes that in light of ACHRE's
report, which:
Highlighted the limited state of knowledge regarding some
key issues in human subjects research . . . NBAC will be re-
viewing and evaluating the IRB Process .... NBAC has un-
dertaken to review the current IRB system and intends to
finish that project within a year. The Administration antici-
pates specific recommendations from NBAC regarding re-
form of IRBs, including recommendations that address
ACHRE's concerns. 58
These concerns include mechanisms to ensure a sharper focus on
studies that pose more than minimal risk to subjects, better ways to
explain the distinction between research and treatment and various
benefits and risks, and ways to ensure that potential subjects under-
stand sponsors and purposes of the research.59
That is an excessively optimistic view of what NBAC can accom-
plish in its effort to understand the possibilities and limitations of
IRBs given the changes in research, sources of funds, and so forth.
Thus, NBAC will probably wait until the results of two other major
studies become available, probably, at least in preliminary form, by the
end of 1997 or early 1998. One of these studies, in an effort to assess
the impact of the reforms carried out in the 1980s and to determine
whether further program refinements are needed, focuses on the 445
57. See generally, U.S. GEN. ACCOUNTING OFFICE, SCIENTIFIC RESEARCH: CONTINUED VIGI-
LANCE CRITICAL TO PROTECTING HUMAN SUBJECTS, B-259279 (1996); Harold Edgar & David
J. Rothman, The Institutional Review Board and Beyond: Future Challenges to the Ethics of Human
Experimentation, 73 THE MILBANK Q. 489 (1995); Phillips, supra note 53.
58. U.S. GOV'T HUMAN RADIATION INTERAGENCY WORKING GROUP, BUILDING PUBLIC
TRUST: ACTIONS TO RESPOND TO THE REPORT OF THE ADVISORY CoMMITTEE ON HUMAN RADI-
ATION EXPERIMENTs 12-13 (1997).
59. See id.
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active IRBs functioning under Multiple Project Assurances. 6° The
other study, being conducted by the Office of Inspector General of
the Department of Health and Human. Services, is designed to ex-
amine the major challenges that face hospital-based IRBs in a chang-
ing healthcare environment, provide promising approaches that these
IRBs have developed to address these challenges, and identify the pol-
icy implications intended to ensure effective IRB functioning for the
Department of Health and Human Services (DHHS)/National Insti-
tute of Health (NIH) and Food and Drug Administration (FDA). 6
Once NBAC has the results of these two -studies, it can determine
whether it has enough information to diagnose problems and make
recommendations or whether it first needs to arrange for additional
studies.
Proposed alternatives- to local IRBs have included regional
boards, national boards, and speciality boards. Mechanisms to supple-
ment or supersede IRB review have developed, both on an ad hoc and
on an extended basis. On the one hand, special review boards have
been used when conflicts have emerged about particular research pro-
tocols. For instance, NIH set up a special review board to examine a
controversial clean-needle exchange program protocol in Anchorage,
Alaska.6" The study will compare health outcomes between partici-
pants who are allowed to exchange dirty -syringes for clean syringes
and participants who would only be instructed on where to purchase
60. See Evaluation of NIH implementation of Section 491 of the Public Health Service
Act, Mandating a Program of Protection for Research Subjects (Charles MacKay, project
officer) (research protocol on file with author). As a condition for receipt of federal re-
search funds, research institutions must assure in writing that personnel will abide by ethi-
cal principles specified in the Belmont Report and 45 C.F.R. § 46. See Alison Wichman,
Protecting Vulnerable Research Subjects: Practical Realities of Institutional Review Board Review and
Approval n.10 and accompanying text, 1 J. HEALTH CARE L. & POL'Y 136 (1997). These
written assurances are referred to as Assurances of Compliance. See id Assurances of Compli-
ance which cover all human subjects research activities carried out by a particular research
institution are referred io as Multiple Project Assurances (MPAs). See id.
Assurances applicable to federally supported or conducted resiarch shall at a
minimum include: (1) a statement of principles governing the institution in the
discharge of its responsibilities . . .(2) designation of one or more IRBs estab-
lished in accordance with the requirements of this policy . . . (3) a list of IRB
members . . . (4) written procedures which the IRB will follow . . . (5) written
procedures for ensuring prompt reporting to the IRB....
45 C.F.R. § 46.103(b)(1)-(5) (1996).
61. Office of Evaluation and Inspections, Office of Inspector General, Department of
Health and Human Services, Hospital-Based IRBs in a Changing Healthcare Environment:
Challenges to Ensuring Human-Subject Protections (OEI-01-97-00190) (March 18, 1997)
(research protocol on file with author).
62. Warren E. Leary, Questions on Ethics Lead to Review of Needle-Exchange Study, N.Y.
TIMES, Oct. 18, 1996, (National), at A22.
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syringes." On the other hand, national review panels have been pro-
posed or used for some types of protocols. For instance, human gene
therapy protocols have been reviewed by the Recombinant DNA Advi-
sory Committee, and it might be plausible to argue for national review
of certain types of protocols, such as xenograft transplants, that raise
public health concerns or that are likely to go beyond the expertise
available at a particular institution.64
E. Gaps Created by Shifting Paradigms of Research
Another gap has emerged because of a fundamental shift in para-
digms of research and, consequently, a shift in the perceptions of ethi-
cal issues in research. The earlier paradigm focused on the risks and
burdens of research and on the need to protect potential and actual
research subjects from harm, abuse, exploitation and the like. The
ethical guidelines for this paradigm emphasized voluntary, informed
consent - that's where the Nuremberg Code begins.6" The basic ap-
proach to research in the United States "was born in scandal and
reared in protectionism."6" The dominant model for such protection-
ist policies is non-therapeutic research, that is, research that doesn't
promise any therapeutic benefit to the subject.
This paradigm has been shifting from protection to access, from
non-therapeutic to therapeutic research (e.g., clinical trials of promis-
ing new therapeutic agents), and from risks and burdens to possible
benefits of clinical research. This shift has resulted particularly (but
not only) because of the epidemic of Human Immunodeficiency Virus
(HIV) infection and Acquired Immunodeficiency Syndrome (AIDS).
AIDS activists pressured the FDA to expand access to new treatments
for those infected with HIV and AIDS.67 They became well informed
about emerging treatments, and they pressured the FDA to expand
the options. 68
63. See id.
64. See, e.g., INSTITUTE OF MEDICINE, XENOTRANSPLANTATION: SCIENCE, ETHICS, AND PUB-
UiC POLICY 2-4 (1996) (recommending that "a mechanism be established within the Depart-
ment of Health and Human Services to ensure needed coordination of the federal
agencies and other entities involved in development, oversight, and evaluation of estab-
lished guidelines").
65. The Nuremberg Code (1948) reprinted in THE NAZI DocroRS AND THE NUREMBURG
CODE 2 (GeorgeJ. Annas & Micheal A. Grodin eds., 1992).
66. Carol Levine, Changing Views ofJustice after Belmont: AIDS and the Inclusion of "Vulner-
able" Subjects, in THE ETHICS OF RESEARCH INVOLVING HUMAN SUIEcrs: FACING THE 21sT
CENTURY 105-06 (Harold Y. Vanderpool ed., 1996).
67. See id. at 107-10.
68. See id.
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The earlier protectionist paradigm should not be completely
abandoned in favor of the newer inclusionist paradigm. We have to
be careful to retain what was important - and remains important -
in the protectionist paradigm even as we incorporate what is impor-
tant in the inclusionist paradigm.
F. Gaps in Compensation for Research-Related Injuries
Injuries sometimes occur in research, despite the best possible
precautions. Some members of the HSSC have expressed an interest
in and support for policies to fill what they perceive to be gaps in
compensation for research-related injuries. However, it is not clear
that this topic will be on NBAC's agenda, because, as another member
put it, "this appears to be a solution in search of a problem, at least
without substantial evidence that some research subjects suffer be-
cause of the lack of a mechanism for compensation."'69 Nevertheless,
in the absence of comprehensive information about the number of
research subjects, it is hard to imagine comprehensive data about the
extent of research-related injuries.
This topic has been discussed for over twenty years, with various
groups recommending compensation for research-related injuries, or
at least a trial period for the compensation program.7" Even though
injuries do not appear to be common, they do occur, and sometimes
deaths even occur. If those injuries are caused by negligence, subjects
have recourse to the tort system. If, however, the injuries are not neg-
ligently caused, subjects usually depend on the generosity of institu-
tions and professionals, since many research protocols do not promise
compensation.
Years ago I argued that compensatory justice requires that-society
compensate subjects for their research related injuries because they
assume a position of risk on behalf of the society, regardless of their
particular motivations for participation in research.71 Another, more
communitarian argument will appear in the next section. Neverthe-
less, it remains to be seen whether NBAC will actually address com-
pensation for research-related injuries.
69. July 15, 1997 Meeting of the NBAC, supra note 48.
70. See, e.g., U.S. DEP'T OF HEALTH, EDUCATION, AND WELFARE, SECRETARY'S TASK FORCE
ON THE COMPENSATION OF INJURED RESEARCH SUBJECTS, DHEW Publication No. OS-77-003
(1977); U.S. PRESIDENT'S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE
AND BIOMEDICAL AND BEHAWoRAL RESEARCH, COMPENSATING FOR RESEARCH INJURIES: A RE-
PORT ON THE ETHICAL AND LEGAL IMPLICATIONS OF PROGRAMS TO REDRESS INJURIES CAUSED
By BIOMEDICAL AND BEHAVIORAL RESEARCH 11-2 (1982).
71. See James F. Childress, Compensating Research-Rdelated Injuries, 6 THE HASTINGS
CENTER REPORT 21, 22 (Dec. 1976).
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G. Gaps in the Belmont Principles and/or in Their Interpretation
Although I have used the metaphor of "gaps," NBAC is not
merely filling holes in regulations and guidelines while leaving un-
changed what is already in place. Much of what NBAC is doing and
will do involves conceptual analysis (e.g., what counts .as "research,"
and which subjects are "vulnerable" and why), and normative deliber-
ation (e.g., which principles and guidelines should govern research
and why). NBAC's charter indicates that it will not review and ap-
prove or disapprove particular research projects; rather it will ex-
amine the "broad, overarching principles to govern the ethical
conduct of research. 1 2 A question has emerged about whether gaps
exist in our current principles.
Three broad principles, articulated by the National Commission
in the 1970s, still govern research involving human subjects.73 Various
guidelines and regulations specify these principles, 74 and, where
guidelines and regulations are incomplete or unclear, IRBs further
interpret the principles to determine whether to approve or reject
particular research protocols. 75 These three principles are as follows:
(1) Respect for Persons: This principle requires that researchers
respect the autonomous choices of those who are autonomous, and
protect those with diminished autonomy.76 Rules of consent/refusal
specify this principle, but in practice the emphasis often falls on the
signed consent form - that is, what local IRBs examine - when what
is critical is the consent process, which is generally not monitored. As
a result, IRBs do not really know - and no one else really knows -
whether the consent process is adequate.
(2) Beneficence: This principle requires benefitting and not
harming. Because both parts often cannot be fully realized simultane-
ously, it is necessary to balance benefits (to subjects and others) and
harms (to subjects only). The rules that specify this principle require
not harming, and also maximizing possible benefits and minimizing
possible harms.
(3) Justice: This principle entails fairness in distributing burdens
and benefits, especially in protecting from exploitation those who
might be selected because of "easy availability .... compromised posi-
72. National Bioethics Advisory Commission Charter (July 26, 1996).
73. Belmont Report, supra note 6, at 3-5.
74. See id. at 3.
75. See it.
76. See id. at 4.
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tion, or... manipulability, rather than for reasons directly related to
the problem being studied."77
At the first NBAC meeting, Commissioner Ezekiel Emanuel con-
tended that these three principles and related guidelines, along with
their interpretations, do not adequately address community.78 Atten-
tion to community could mean, among other possibilities, that we
should add community as a fourth principle or that we should inter-
pret all of these principles in a communitarian rather than a merely
individualistic manner. This second approach would involve reexam-
ining the principles and guidelines through the lens of community.
At any rate, it is likely that NBAC will reconsider these principles to
make certain that community is sufficiently included. Following are a
few illustrations of what this might mean.
Reinterpreted through the lens of community, the principle of
respect for persons would consider participants not merely as isolated
individuals, who consent or refuse to consent to participation in re-
search, but also as members of the community. However, caution is
also appropriate because it is not possible or justifiable to determine
an individual's wishes and choices by extrapolating them from com-
munity traditions, beliefs, and values.
Beneficence already includes attention to society's welfare, which
has been part of the benefit to be balanced against the risks to sub-
jects. However, attention to community might also require, as has be-
come more common, attention to the harms to a particular
community, such as the Native American community, rather than
merely harms to individuals.
Justice, as a final example, concerns more than fairly selecting
research subjects and fairly distributing the benefits and burdens of
participation in research. It may include the participation of various
communities in the design and evaluation of research. Beyond partic-
ipation, it might include compensation for research-related injuries as
an expression of the community's solidarity with research subjects
who assume a position of risk on behalf of the community and who
are non-negligently injured in the process. From this standpoint, it
might not be sufficient to disclose on the consent form whether there
will be any compensation for research-related injuries that are non-
negligently caused; instead, compensation should be provided.79
77. Id. at 5.
78. Meeting of the National Bioethics Advisory Committee (Oct. 4, 1996) (unpub-
lished transcript, on file with Journal of Health Care Law & Policy).
79. At its November 1996 meeting with representatives of commissions in other coun-
tries, NBAC learned that other countries, with a commitment to universal access to health
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As the above examples suggest, it is important to revisit these
principles in light of concerns about community, but to do so in a way
that does not neglect or distort what is important in earlier, more indi-
vidualistic interpretations. It is presently unclear what might emerge
if NBAC takes this course. At the very least, NBAC expects to contract
for a paper that examines the concept of community and its possible
uses in research involving human subjects. Another paper, currently
under contract, will examine vulnerability from a relational perspec-
tive. This latter paper could propose another way to move beyond
construing the potential or actual research subject as an isolated indi-
vidual, and beyond viewing vulnerability mainly as a problem of the
potential research subject and his/her institutional setting (e.g., a
prison).
H. Gaps in Public Trust
One indication of the lack of community in our society is that
some groups lack trust in researchers and research institutions. For
example, there is evidence that the story of the federal government's
syphilis study in Tuskegee, Alabama, continues to breed distrust
among African-Americans. This distrust can thwart participation in
research as well as have a negative impact on the donation of organs
for transplantation, and even adversely affect willingness to seek medi-
cal care.80
In part as a way to restore a sense of community, President Clin-
ton, this past spring, publicly apologized to the few survivors and rela-
tives of the 399 African-American subjects of the federal government's
syphilis study in Tuskegee. 8' President Clinton stated that the United
States Government "did something that was wrong - deeply, pro-
foundly, morally wrong. It was an outrage to our commitment to in-
tegrity and equality for all our citizens.... We cannot be one America
when a whole segment of our nation has no trust in America."82
NBAC had earlier supported public calls for a presidential apology,
and endorsed administration consideration of the recommendations
care, do not view compensation for research-related injuries as a problem. Meeting of the
National Bioethics Advisory Committee (November 21, 1996) (unpublished transcript, on
file with Journal of Health Care Law & Policy). Such injuries would be routinely covered, at
least for medical expenses. Id. Of course, there are always questions of the scope of com-
pensation. Id.
80. Jeff Stryker, Tuskegee's Long Arm Still Touches a Nerve, N.Y. TIMEs, April 13, 1997, at
Sec. 4, at 4.
81. Alison Mitchell, Survivors of Tuskegee Study Get Apology From Clinton, N.Y. TIMES, May
17, 1997, at Sec. 1, at 10.
82. Id.
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of the Tuskegee -Syphilis Study Legacy Committee."3 As part of his
apology, President Clinton announced a $200,000 planning grant to
Tuskegee University to help establish and create a Center for
Bioethics in Research and Health Care, and fellowships for post-grad-
uate studies in bioethics, with special attention placed on minority stu-
dent recruitment.8 4 Furthermore, President Clinton asked Donna
Shalala, the Secretary of the Department of Health and Human Serv-
ices, to report within six months on how communities, especially mi-
nority communities, could be involved in research and assessing
health care, particularly in view of widespread attitudes of distrust.8 5
As an additional action, President Clinton extended NBAC's life until
1999.86
IV. CONCLUSIONS
I have used the metaphor of gaps to suggest some concerns that
members of NBAC and others have raised about the protection of
human subjects in biomedical and behavioral research.8 7 It is not
clear how well NBAC, even with an extended life expectancy, a more
adequate budget, and valuable testimony and studies provided by
others, can close gaps in information that may be important in revis-
ing policies to protect human subjects. Important gaps in knowledge
include, for example, the way IRBs function. There are also gaps in
our knowledge about the process of informed consent, in contrast to
our information about consent forms. It is often noted that we have
more information about animals in research than about humans in
research. A fundamental question facing NBAC is how much infor-
mation is necessary in order to identify a substantive or procedural
gap in need of attention.
Finally, even though the metaphor of gaps is suggestive, it is not
fully adequate. Protection of human research subjects may fail be-
cause substantive and procedural guidelines are too complex and thus
83. The Tuskegee Syphilis Study Legacy Comm., Final Report of the Tuskegee Syphilis
Study Committee (May 20, 1996) (unpublished report, on file with Journal of Health Care
Law & Policy); see generally Meeting of the National Bioethics Advisory Committee (Mar. 13,
1997) (unpublished transcript, on file with the Journal of Health Care Law & Policy).
84. See Mitchell, supra note 81, at 10.
85. See i&L
86. See i&.
87. One major gap I have not discussed in this paper concerns international research,
especially research funded by developed countries but conducted in developing countries.
It appears that NBAC will take up this topic, at least to some extent. SeeJuly 15, 1997
Meeting of the NBAC, supra note 48 at 123-25). For an excellent set of essays on this topic,
see THE ETHICS OF RESEARCH INVOLVING HUMAN SUBJECTS: FACING THE 21sT CENruRY ch. 10-
12 (Harold Y. Vanderpool ed., 1996).
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too burdensome. As a result, many believe that investigators and IRBs
spend too much time, energy, and resources on what is not so impor-
tant and too little time, energy, and resources on what really is impor-
tant. Hence, some propose that if NBAC attempts to close some gaps
in substantive and procedural guidelines, it should also try to reduce
requirements that are less important or suggest that they receive less
attention or lower priority.
